A gluten-free diet alone may be insufficient for treating celiac disease. Alvine Pharmaceuticals has just released the results of its fourth clinical trial of ALV003, an enzyme which digests the gluten present in a meal. I consider this to be one of the most promising results in celiac disease research in the past year!
I have reviewed the clinical trials of ALV003, and discuss the implications of this drug for celiacs.
Exciting Developments in Gluten Digestion for Celiacs — Results from Four Clinical Trials of ALV003Best Regards,
Peter
